Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

The recent finding that MYC-driven cancers are sensitive to inhibition of the DNA damage response (DDR) pathway, prompted us to investigate the role of DDR pathway as therapeutic target in diffuse large B-cell lymphoma (DLBCL), which frequently overexpresses the MYC oncogene. In a preliminary immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Derenzini, Enrico, Agostinelli, Claudio, Imbrogno, Enrica, Iacobucci, Ilaria, Casadei, Beatrice, Brighenti, Elisa, Righi, Simona, Fuligni, Fabio, Di Rorà, Andrea Ghelli Luserna, Ferrari, Anna, Martinelli, Giovanni, Pileri, Stefano, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466634/
https://www.ncbi.nlm.nih.gov/pubmed/25544753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466634/
https://www.ncbi.nlm.nih.gov/pubmed/25544753

Ejemplares similares